Clinical consequences of the use of highly purified silicone oil: Comparative study of highly and less purified silicone oil

European Journal of Ophthalmology

Volumn 8, Issue 3, 1998, Pages 179-183

  Pastor, J C ^a   Zarco, J M ^a   Del Nozal, M J ^a   Pampliega, A ^a   Marinero, P ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Emulsification; Ocular toxicity; Preretinal reproliferation; Silicone oil; Vitrectomy; Vitreous substitute

Indexed keywords

SILICONE OIL;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; DRUG PURITY; EYE TOXICITY; FOLLOW UP; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; INTRAOCULAR HYPERTENSION; INTRAOCULAR HYPOTENSION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETINA CELL; RETINA DETACHMENT;

EID: 0031752003     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067219800800311     Document Type: Article

References (18)

1. Sparrow JR, Chang S. Vitreous substitutes. In: Albert, Jakobiec, eds. Principles and practice of ophthalmology. Philadelphia: WB Saunders Company, 1994; 1142-59.
2. Gabel VP, Kampik A, Burkhardt J. Analysis of intraocularly applied silicone oils of various origins. Graefe's Arch Clin Exp Ophthalmol 1987; 225: 160-2.
3. Nakamura K, Refojo MF, Crabtree DV, Pastor J, Leong FL. Ocular toxicity of low-molecular-weight components of silicone and fluorosilicone oils. Invest Ophthalmol Vis Sci 1991; 32: 3007-20.
4. Pastor JC, Lopez MI, Saornil MA, Refojo MF. Intravitreal silicone and fluorosilicone oils: pathologic findings in rabbit eyes. Acta Ophthalmol 1992; 70: 651-8.
5. Nakamura K, Refojo MF, Crabtree DV, Leong FL. Analysis and fractionation of silicone and fluorosilicone oils for intraocular use. Invest Ophthalmol Vis Sci 1990; 31: 2059-69.
6. Lean JS, Stern WH, Irvine AR, Azen SP. Classification of proliferative vitreoretinopathy used in the silicone study. Ophthalmology 1989; 96: 765-71.
7. Federman JL, Schubert HD. Complications associated with the use of silicone oil in 150 eyes after retinal vitreous surgery. Ophthalmology 1988; 95: 870-6.
8. Chan C, Okun E. The question of ocular tolerance to intravitreal liquid silicone. A long-term analysis. Ophthalmology 1986; 651-60.
9. Barr CC, Lay MY, Lean JS, et al. Postoperative intraocular pressure abnormalities in the silicone study. Silicone Study report 4. Ophthalmology 1993; 100: 1629-35.
10. Valone J Jr, McCarthy M. Emulsified anterior chamber silicone oil and glaucoma. Ophthalmology 1994; 101: 1908-12.
11. Nguyen QH, Lloyd MA, Heuer DK, et al. Incidence and management of glaucoma after intravitreal silicone oil injection for complicated retinal detachments. Ophthalmology 1992; 99: 1520-6.
12. Sternberg P Jr, Hatchell DL, Foulks GN, Landers MB. The effect of silicone oil on the cornea. Arch Ophthalmol 1985; 103: 90-4.
13. Crisp A, de Jan E Jr, Tiedeman J. Effect of silicone oil viscosity on emulsification. Arch Ophthalmol 1987; 105: 546-50.
14. Nakamura K, Refojo MF, Crabtree DV. Factors contributing to the emulsification of intraocular silicone and fluorosilicone oils. Invest Ophthalmol Vis Sci 1990; 31: 647-56.
15. Lambrou FH, Burke JM, Aaberg TM. Effect of silicone oil on experimental traction retinal detachment. Arch Ophthalmol 1987; 105: 1269-72.
16. Fastenberg DM, Diddle KR, Delmage JM, Dorey K. Intraocular injection of silicone oil for experimental proliferative vitreoretinopathy. Am J Ophthalmol 1983; 95: 663-7.
17. Lewis H, Burke JM, Abrams GW, Aaberg TM. Persilicone proliferation after vitrectomy for proliferative vitreoretinopathy. Ophthalmology 1988; 95: 583-91.
18. Kreiner CF. Chemical and physical aspects of clinically applied silicones. Dev Ophthalmol 1987; 14: 11-9.